questionsmedicales.fr
Composés polycycliques
Hydrocarbures aromatiques polycycliques
Phénanthrènes
Morphinanes
Morphinanes : Questions médicales fréquentes
Diagnostic
5
Dépendance aux opioïdes
Morphinanes
Tests de dépistage
Morphinanes
Douleur chronique
Morphinanes
Symptômes
5
Effets indésirables
Morphinanes
Réaction allergique
Morphinanes
Dépendance aux opioïdes
Morphinanes
Prévention
5
Prévention de la dépendance
Morphinanes
Éducation à la santé
Morphinanes
Conseils aux patients
Morphinanes
Surveillance médicale
Morphinanes
Traitements
5
Traitement de la dépendance
Morphinanes
Effets indésirables
Morphinanes
Complications
5
Complications
Morphinanes
Santé mentale
Morphinanes
Troubles gastro-intestinaux
Morphinanes
Abus de substances
Morphinanes
Facteurs de risque
5
Facteurs de risque
Dépendance aux opioïdes
Comportements à risque
Morphinanes
Santé mentale
Dépendance aux opioïdes
Environnement
Morphinanes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Morphinanes : Questions médicales les plus fréquentes",
"headline": "Morphinanes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Morphinanes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-26",
"dateModified": "2025-12-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Morphinanes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénanthrènes",
"url": "https://questionsmedicales.fr/mesh/D010616",
"about": {
"@type": "MedicalCondition",
"name": "Phénanthrènes",
"code": {
"@type": "MedicalCode",
"code": "D010616",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Benzomorphanes",
"alternateName": "Benzomorphans",
"url": "https://questionsmedicales.fr/mesh/D001575",
"about": {
"@type": "MedicalCondition",
"name": "Benzomorphanes",
"code": {
"@type": "MedicalCode",
"code": "D001575",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.106"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Pentazocine",
"alternateName": "Pentazocine",
"url": "https://questionsmedicales.fr/mesh/D010423",
"about": {
"@type": "MedicalCondition",
"name": "Pentazocine",
"code": {
"@type": "MedicalCode",
"code": "D010423",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.106.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phénazocine",
"alternateName": "Phenazocine",
"url": "https://questionsmedicales.fr/mesh/D010620",
"about": {
"@type": "MedicalCondition",
"name": "Phénazocine",
"code": {
"@type": "MedicalCode",
"code": "D010620",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.106.715"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Buprénorphine",
"alternateName": "Buprenorphine",
"url": "https://questionsmedicales.fr/mesh/D002047",
"about": {
"@type": "MedicalCondition",
"name": "Buprénorphine",
"code": {
"@type": "MedicalCode",
"code": "D002047",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Butorphanol",
"alternateName": "Butorphanol",
"url": "https://questionsmedicales.fr/mesh/D002077",
"about": {
"@type": "MedicalCondition",
"name": "Butorphanol",
"code": {
"@type": "MedicalCode",
"code": "D002077",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.165"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dextrométhorphane",
"alternateName": "Dextromethorphan",
"url": "https://questionsmedicales.fr/mesh/D003915",
"about": {
"@type": "MedicalCondition",
"name": "Dextrométhorphane",
"code": {
"@type": "MedicalCode",
"code": "D003915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dextrorphane",
"alternateName": "Dextrorphan",
"url": "https://questionsmedicales.fr/mesh/D003917",
"about": {
"@type": "MedicalCondition",
"name": "Dextrorphane",
"code": {
"@type": "MedicalCode",
"code": "D003917",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.235"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diprénorphine",
"alternateName": "Diprenorphine",
"url": "https://questionsmedicales.fr/mesh/D004174",
"about": {
"@type": "MedicalCondition",
"name": "Diprénorphine",
"code": {
"@type": "MedicalCode",
"code": "D004174",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Étorphine",
"alternateName": "Etorphine",
"url": "https://questionsmedicales.fr/mesh/D005048",
"about": {
"@type": "MedicalCondition",
"name": "Étorphine",
"code": {
"@type": "MedicalCode",
"code": "D005048",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.270"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lévallorphane",
"alternateName": "Levallorphan",
"url": "https://questionsmedicales.fr/mesh/D007977",
"about": {
"@type": "MedicalCondition",
"name": "Lévallorphane",
"code": {
"@type": "MedicalCode",
"code": "D007977",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.413"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lévorphanol",
"alternateName": "Levorphanol",
"url": "https://questionsmedicales.fr/mesh/D007981",
"about": {
"@type": "MedicalCondition",
"name": "Lévorphanol",
"code": {
"@type": "MedicalCode",
"code": "D007981",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.463"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dérivés de la morphine",
"alternateName": "Morphine Derivatives",
"url": "https://questionsmedicales.fr/mesh/D009022",
"about": {
"@type": "MedicalCondition",
"name": "Dérivés de la morphine",
"code": {
"@type": "MedicalCode",
"code": "D009022",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Codéine",
"alternateName": "Codeine",
"url": "https://questionsmedicales.fr/mesh/D003061",
"about": {
"@type": "MedicalCondition",
"name": "Codéine",
"code": {
"@type": "MedicalCode",
"code": "D003061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.149"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hydrocodone",
"alternateName": "Hydrocodone",
"url": "https://questionsmedicales.fr/mesh/D006853",
"about": {
"@type": "MedicalCondition",
"name": "Hydrocodone",
"code": {
"@type": "MedicalCode",
"code": "D006853",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.149.287"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oxycodone",
"alternateName": "Oxycodone",
"url": "https://questionsmedicales.fr/mesh/D010098",
"about": {
"@type": "MedicalCondition",
"name": "Oxycodone",
"code": {
"@type": "MedicalCode",
"code": "D010098",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.149.575"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hydrocodone",
"alternateName": "Hydrocodone",
"url": "https://questionsmedicales.fr/mesh/D006853",
"about": {
"@type": "MedicalCondition",
"name": "Hydrocodone",
"code": {
"@type": "MedicalCode",
"code": "D006853",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.149.287"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oxycodone",
"alternateName": "Oxycodone",
"url": "https://questionsmedicales.fr/mesh/D010098",
"about": {
"@type": "MedicalCondition",
"name": "Oxycodone",
"code": {
"@type": "MedicalCode",
"code": "D010098",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.149.575"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydromorphine",
"alternateName": "Dihydromorphine",
"url": "https://questionsmedicales.fr/mesh/D004090",
"about": {
"@type": "MedicalCondition",
"name": "Dihydromorphine",
"code": {
"@type": "MedicalCode",
"code": "D004090",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Éthylmorphine",
"alternateName": "Ethylmorphine",
"url": "https://questionsmedicales.fr/mesh/D005036",
"about": {
"@type": "MedicalCondition",
"name": "Éthylmorphine",
"code": {
"@type": "MedicalCode",
"code": "D005036",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.430"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Héroïne",
"alternateName": "Heroin",
"url": "https://questionsmedicales.fr/mesh/D003932",
"about": {
"@type": "MedicalCondition",
"name": "Héroïne",
"code": {
"@type": "MedicalCode",
"code": "D003932",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.445"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hydromorphone",
"alternateName": "Hydromorphone",
"url": "https://questionsmedicales.fr/mesh/D004091",
"about": {
"@type": "MedicalCondition",
"name": "Hydromorphone",
"code": {
"@type": "MedicalCode",
"code": "D004091",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Morphine",
"alternateName": "Morphine",
"url": "https://questionsmedicales.fr/mesh/D009020",
"about": {
"@type": "MedicalCondition",
"name": "Morphine",
"code": {
"@type": "MedicalCode",
"code": "D009020",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.571"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oxymorphone",
"alternateName": "Oxymorphone",
"url": "https://questionsmedicales.fr/mesh/D010111",
"about": {
"@type": "MedicalCondition",
"name": "Oxymorphone",
"code": {
"@type": "MedicalCode",
"code": "D010111",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.692"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thébaïne",
"alternateName": "Thebaine",
"url": "https://questionsmedicales.fr/mesh/D013797",
"about": {
"@type": "MedicalCondition",
"name": "Thébaïne",
"code": {
"@type": "MedicalCode",
"code": "D013797",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.856"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nalbuphine",
"alternateName": "Nalbuphine",
"url": "https://questionsmedicales.fr/mesh/D009266",
"about": {
"@type": "MedicalCondition",
"name": "Nalbuphine",
"code": {
"@type": "MedicalCode",
"code": "D009266",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.606"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nalorphine",
"alternateName": "Nalorphine",
"url": "https://questionsmedicales.fr/mesh/D009269",
"about": {
"@type": "MedicalCondition",
"name": "Nalorphine",
"code": {
"@type": "MedicalCode",
"code": "D009269",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.656"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Naloxone",
"alternateName": "Naloxone",
"url": "https://questionsmedicales.fr/mesh/D009270",
"about": {
"@type": "MedicalCondition",
"name": "Naloxone",
"code": {
"@type": "MedicalCode",
"code": "D009270",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.706"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Naltrexone",
"alternateName": "Naltrexone",
"url": "https://questionsmedicales.fr/mesh/D009271",
"about": {
"@type": "MedicalCondition",
"name": "Naltrexone",
"code": {
"@type": "MedicalCode",
"code": "D009271",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.706.550"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Morphinanes",
"alternateName": "Morphinans",
"code": {
"@type": "MedicalCode",
"code": "D009019",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tsuyoshi Saitoh",
"url": "https://questionsmedicales.fr/author/Tsuyoshi%20Saitoh",
"affiliation": {
"@type": "Organization",
"name": "International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan; Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan; Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan."
}
},
{
"@type": "Person",
"name": "Hiroshi Nagase",
"url": "https://questionsmedicales.fr/author/Hiroshi%20Nagase",
"affiliation": {
"@type": "Organization",
"name": "Degree Programs in Pure and Applied Sciences, Graduate School of Science and Technology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8571, Japan; International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. Electronic address: nagase.hiroshi.gt@u.tsukuba.ac.jp."
}
},
{
"@type": "Person",
"name": "Dana E Selley",
"url": "https://questionsmedicales.fr/author/Dana%20E%20Selley",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology and Toxicology , Virginia Commonwealth University , 410 North 12th Street , Richmond , Virginia 23298 , United States."
}
},
{
"@type": "Person",
"name": "Yan Zhang",
"url": "https://questionsmedicales.fr/author/Yan%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicinal Chemistry, School of Pharmacy , Virginia Commonwealth University , 800 E Leigh Street , Richmond , Virginia 23298 , United States."
}
},
{
"@type": "Person",
"name": "Akihisa Tokuda",
"url": "https://questionsmedicales.fr/author/Akihisa%20Tokuda",
"affiliation": {
"@type": "Organization",
"name": "Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Chemistry and biology of ent-morphinan alkaloids.",
"datePublished": "2023-09-07",
"url": "https://questionsmedicales.fr/article/37716795",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/bs.alkal.2023.07.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Peripheralization Strategies Applied to Morphinans and Implications for Improved Treatment of Pain.",
"datePublished": "2023-06-14",
"url": "https://questionsmedicales.fr/article/37375318",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules28124761"
}
},
{
"@type": "ScholarlyArticle",
"name": "Design and synthesis of unique morphinan-type molecules: Their application to the search for the unexplored binding domain between opioid receptors and morphinan ligands.",
"datePublished": "2024-01-14",
"url": "https://questionsmedicales.fr/article/38228254",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bmcl.2024.129611"
}
},
{
"@type": "ScholarlyArticle",
"name": "Morphinan and isoquinoline alkaloids from the tuberous roots of",
"datePublished": "2023-11-09",
"url": "https://questionsmedicales.fr/article/37943069",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14786419.2023.2275740"
}
},
{
"@type": "ScholarlyArticle",
"name": "Morphinan Evolution: The Impact of Advances in Biochemistry and Molecular Biology.",
"datePublished": "2024-02-21",
"url": "https://questionsmedicales.fr/article/38382631",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/jb/mvae021"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés polycycliques",
"item": "https://questionsmedicales.fr/mesh/D011083"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures aromatiques polycycliques",
"item": "https://questionsmedicales.fr/mesh/D011084"
},
{
"@type": "ListItem",
"position": 4,
"name": "Phénanthrènes",
"item": "https://questionsmedicales.fr/mesh/D010616"
},
{
"@type": "ListItem",
"position": 5,
"name": "Morphinanes",
"item": "https://questionsmedicales.fr/mesh/D009019"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Morphinanes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Morphinanes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Morphinanes",
"description": "Comment diagnostiquer une dépendance aux morphinanes ?\nQuels tests sont utilisés pour détecter les morphinanes ?\nQuels signes cliniques indiquent une intoxication aux morphinanes ?\nComment évaluer la sévérité d'une overdose de morphinanes ?\nQuels critères sont utilisés pour le diagnostic de douleur chronique ?",
"url": "https://questionsmedicales.fr/mesh/D009019#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Morphinanes",
"description": "Quels sont les symptômes d'une overdose de morphinanes ?\nQuels effets secondaires sont associés aux morphinanes ?\nComment reconnaître une réaction allergique aux morphinanes ?\nQuels symptômes indiquent une dépendance aux morphinanes ?\nQuels signes d'overdose nécessitent une intervention immédiate ?",
"url": "https://questionsmedicales.fr/mesh/D009019#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Morphinanes",
"description": "Comment prévenir la dépendance aux morphinanes ?\nQuelles mesures peuvent réduire le risque d'overdose ?\nComment sensibiliser aux dangers des morphinanes ?\nQuels conseils donner aux patients sur l'utilisation des morphinanes ?\nComment surveiller l'usage des morphinanes chez les patients ?",
"url": "https://questionsmedicales.fr/mesh/D009019#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Morphinanes",
"description": "Quels traitements sont disponibles pour la dépendance aux morphinanes ?\nComment traiter une overdose de morphinanes ?\nQuels médicaments sont utilisés pour soulager la douleur ?\nComment gérer les effets secondaires des morphinanes ?\nQuelles sont les alternatives aux morphinanes pour la douleur ?",
"url": "https://questionsmedicales.fr/mesh/D009019#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Morphinanes",
"description": "Quelles complications peuvent survenir avec l'usage prolongé de morphinanes ?\nComment les morphinanes affectent-ils la santé mentale ?\nQuels risques sont associés à l'overdose de morphinanes ?\nComment les morphinanes peuvent-ils affecter le système digestif ?\nQuelles sont les conséquences d'une utilisation abusive de morphinanes ?",
"url": "https://questionsmedicales.fr/mesh/D009019#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Morphinanes",
"description": "Quels facteurs augmentent le risque de dépendance aux morphinanes ?\nComment l'âge influence-t-il le risque d'overdose de morphinanes ?\nQuels comportements augmentent le risque d'abus de morphinanes ?\nComment les problèmes de santé mentale influencent-ils l'usage des morphinanes ?\nQuels facteurs environnementaux peuvent influencer l'usage des morphinanes ?",
"url": "https://questionsmedicales.fr/mesh/D009019#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dépendance aux morphinanes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation des symptômes et l'historique d'usage."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les morphinanes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests urinaires et sanguins peuvent détecter la présence de morphinanes."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une intoxication aux morphinanes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent somnolence, confusion, et dépression respiratoire."
}
},
{
"@type": "Question",
"name": "Comment évaluer la sévérité d'une overdose de morphinanes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par l'examen clinique et l'analyse des signes vitaux."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic de douleur chronique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la durée de la douleur et son impact sur la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une overdose de morphinanes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent respiration lente, confusion, et perte de conscience."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires sont associés aux morphinanes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure constipation, nausées et somnolence."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux morphinanes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les réactions allergiques peuvent se manifester par éruptions cutanées et démangeaisons."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dépendance aux morphinanes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent cravings, tolérance accrue et symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Quels signes d'overdose nécessitent une intervention immédiate ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une respiration très lente et une perte de conscience."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dépendance aux morphinanes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une prescription prudente et une éducation des patients."
}
},
{
"@type": "Question",
"name": "Quelles mesures peuvent réduire le risque d'overdose ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'usage combiné avec d'autres dépresseurs et suivre les doses prescrites."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser aux dangers des morphinanes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes d'éducation et des programmes de sensibilisation sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels conseils donner aux patients sur l'utilisation des morphinanes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur les risques, les effets secondaires et l'importance de suivre les prescriptions."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'usage des morphinanes chez les patients ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suivis réguliers et des évaluations de la douleur sont recommandés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la dépendance aux morphinanes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie comportementale et les médicaments comme la méthadone."
}
},
{
"@type": "Question",
"name": "Comment traiter une overdose de morphinanes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'administration de naloxone est essentielle pour inverser les effets d'une overdose."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour soulager la douleur ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les morphinanes sont souvent prescrits pour traiter des douleurs modérées à sévères."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires des morphinanes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments anti-nauséeux et des laxatifs peuvent aider à gérer les effets secondaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les alternatives aux morphinanes pour la douleur ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les alternatives incluent les anti-inflammatoires non stéroïdiens et les antidouleurs non opioïdes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'usage prolongé de morphinanes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dépendance, la tolérance et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Comment les morphinanes affectent-ils la santé mentale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'usage prolongé peut entraîner des troubles de l'humeur et des problèmes cognitifs."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à l'overdose de morphinanes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des lésions cérébrales, des arrêts respiratoires et la mort."
}
},
{
"@type": "Question",
"name": "Comment les morphinanes peuvent-ils affecter le système digestif ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer une constipation sévère et d'autres troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une utilisation abusive de morphinanes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation abusive peut entraîner des problèmes de santé physique et mentale graves."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dépendance aux morphinanes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de dépendance et les troubles mentaux augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque d'overdose de morphinanes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées sont plus à risque en raison de la polypharmacie et de la sensibilité."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque d'abus de morphinanes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'usage récréatif et le partage de médicaments augmentent le risque d'abus."
}
},
{
"@type": "Question",
"name": "Comment les problèmes de santé mentale influencent-ils l'usage des morphinanes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles mentaux peuvent conduire à une utilisation inappropriée et à la dépendance."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux peuvent influencer l'usage des morphinanes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement social permissif et l'accès facile aux médicaments augmentent le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 16/12/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan; Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan; Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Publications dans "Morphinanes" :
4 publications dans cette catégorie
Affiliations :
Degree Programs in Pure and Applied Sciences, Graduate School of Science and Technology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8571, Japan; International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. Electronic address: nagase.hiroshi.gt@u.tsukuba.ac.jp.
Publications dans "Morphinanes" :
4 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology , Virginia Commonwealth University , 410 North 12th Street , Richmond , Virginia 23298 , United States.
Publications dans "Morphinanes" :
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment.
ACS chemical neuroscience
2019-02-21
Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4'-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptors.
Bioorganic chemistry
2021-02-09
Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder.
European journal of pharmacology
2019-11-16
Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands.
Journal of medicinal chemistry
2019-01-11
4 publications dans cette catégorie
Affiliations :
Department of Medicinal Chemistry, School of Pharmacy , Virginia Commonwealth University , 800 E Leigh Street , Richmond , Virginia 23298 , United States.
Publications dans "Morphinanes" :
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment.
ACS chemical neuroscience
2019-02-21
Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4'-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptors.
Bioorganic chemistry
2021-02-09
Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder.
European journal of pharmacology
2019-11-16
Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands.
Journal of medicinal chemistry
2019-01-11
3 publications dans cette catégorie
Affiliations :
Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Publications dans "Morphinanes" :
3 publications dans cette catégorie
Affiliations :
Degree Programs in Pure and Applied Sciences, Graduate School of Science and Technology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8571, Japan; International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan; Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. Electronic address: kutsumura.noriki.gn@u.tsukuba.ac.jp.
Publications dans "Morphinanes" :
3 publications dans cette catégorie
Affiliations :
Department of Medicinal Chemistry, School of Pharmacy , Virginia Commonwealth University , 800 E Leigh Street , Richmond , Virginia 23298 , United States.
Publications dans "Morphinanes" :
3 publications dans cette catégorie
Affiliations :
Department of Medicinal Chemistry, School of Pharmacy , Virginia Commonwealth University , 800 E Leigh Street , Richmond , Virginia 23298 , United States.
Publications dans "Morphinanes" :
3 publications dans cette catégorie
Affiliations :
Department of Medicinal Chemistry, School of Pharmacy , Virginia Commonwealth University , 800 E Leigh Street , Richmond , Virginia 23298 , United States.
Publications dans "Morphinanes" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacology , Lewis Katz School of Medicine, Temple University , Philadelphia , Pennsylvania 19140 , United States.
Publications dans "Morphinanes" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacology , Lewis Katz School of Medicine, Temple University , Philadelphia , Pennsylvania 19140 , United States.
Publications dans "Morphinanes" :
2 publications dans cette catégorie
Affiliations :
Degree Programs in Pure and Applied Sciences, Graduate School of Science and Technology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8571, Japan.
Publications dans "Morphinanes" :
2 publications dans cette catégorie
Affiliations :
International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
Publications dans "Morphinanes" :
2 publications dans cette catégorie
Affiliations :
International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
Publications dans "Morphinanes" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology , Virginia Commonwealth University , 410 North 12th Street , Richmond , Virginia 23298 , United States.
Publications dans "Morphinanes" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology , Virginia Commonwealth University , 410 North 12th Street , Richmond , Virginia 23298 , United States.
Publications dans "Morphinanes" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology , Virginia Commonwealth University , 410 North 12th Street , Richmond , Virginia 23298 , United States.
Publications dans "Morphinanes" :
1 publication dans cette catégorie
Affiliations :
ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH, Heinrich-Glaeser-Strasse 10-14, D-01454 Radeberg, Germany.
Publications dans "Morphinanes" :
1 publication dans cette catégorie
Affiliations :
Department of Medical Imaging, Division of Nuclear Medicine and Translational Imaging, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, H-4032 Debrecen, Hungary.
Publications dans "Morphinanes" :
1 publication dans cette catégorie
Affiliations :
Department of Nuclear Medicine, Bern University Hospital, Freiburgstraße 18, 3010 Bern, Switzerland.
School of Psychology and Counselling, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Publications dans "Morphinanes" :
Morphinan alkaloids have attracted constant attention since the isolation of morphine by Sertürner in 1805. However, a group of 45 compounds possessing a complete ent-morphinan backbone can also be fo...
Opioids are considered the most effective analgesics for the treatment of moderate to severe acute and chronic pain. However, the inadequate benefit/risk ratio of currently available opioids, together...
The morphinan skeleton is valued in drug discovery for its beneficial physicochemical properties and is recognized as a crucial template for opioid receptor ligands. In morphinan derivatives, it is we...
A new morphinan alkaloid (6...
Morphinan-based opioids, derived from natural alkaloids like morphine, codeine, and thebaine, have long been pivotal in managing severe pain. However, their clinical utility is marred by significant s...
Morphinan antagonists, which block opioid effects at mu-opioid receptors, have been studied for their analgesic potential. Previous studies have suggested that these antagonists elicit analgesia with ...
The reaction of 14-aminonaltrexone with acetic anhydride was found to produce a range of different novel compounds between the free compound and its hydrochloride. The hydrochloride produced a compoun...
Due to the gastrointestinal side effects, the clinical application of sinomenine hydrochloride (SH) in rheumatoid arthritis is limited. The elderly population constitutes the primary group affected by...
Ferritinophagy is a cellular process to release redox-active iron. Excessive activation of ferritinophagy ultimately results in ferroptosis characterized by ROS accumulation which plays important role...
Defluorination of the readily available 21,21,21-trifluorothevinone (7) with Mg + Me...